GATA3 and neoplasm: Parameters for luminal tumor phenotype—which was linked to favorable disease outcome in studies analyzing RNA—such as uroplakin 1a, uroplakin 1b, or GATA3 were also unrelated to patient outcome in our cohort of more than 600 muscle-invasive carcinomas in recent studies [11, 23].